Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05243290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nicotinamide Riboside Clinical Trial for GWI

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Primary completion date: Feb 15, 2025 to Apr 30, 2025
    • Study completion date: Feb 15, 2025 to Dec 31, 2025
    • Site contacts updated at 2 of 2 sites
    v8
  3. Site contacts updated at 2 of 2 sitesv7
  4. Primary and study completion dates: Feb 15, 2024 to Feb 15, 2025v6
  5. Site contacts updated at 1 of 2 sitesv5
Show 3 earlier versionsHide 3 earlier versions
  1. Site contacts updated at 1 of 2 sitesv4
  2. Eligibility criteria revised
    • Site details revised at 2 of 2 sites
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 15, 2022 to Apr 13, 2022
    • Site details revised at 2 of 2 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this multi-site trial, we will use a randomized, double-blind, placebo-controlled study design to test whether 300 mg of Nicotinamide Riboside (NR) can achieve the primary objective of increasing plasma NAD+ levels in participants with Gulf War Illness (GWI).
Trial Details
NCT Number NCT05243290
Lead Sponsor Roskamp Institute Inc.
Collaborators: United States Department of Defense, Nova Southeastern University
Conditions
(from sponsor)		 Gulf War Illness
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov